Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine

M. N. Chieppa, A. Perota, C. Corona, A. Grindatto, I. Lagutina, E. Vallino Costassa, G. Lazzari, S. Colleoni, R. Duchi, F. Lucchini, M. Caramelli, C. Bendotti, C. Galli, C. Casalone

Research output: Contribution to journalArticle

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that occurs in two clinically indistinguishable forms: sporadic (SALS) and familial (FALS), the latter linked to several gene mutations, mostly inheritable in a dominant manner. Nearly 20% of FALS forms are linked to mutations in the Cu/Zn superoxide dismutase (SOD1) gene. Research on ALS relies on transgenic models and particularly on mice carrying a glycine-to-alanine conversion at the 93rd codon (G93A) of the hSOD1 gene. Although G93A transgenic mice have been widely employed in clinical trials and basic research, doubts have been recently raised from numerous reliable sources about their suitability to faithfully reproduce human disease. Besides, the scientific community has already foreseen swine as an attractive and alternative model to nonhuman primates for modeling human diseases due to closer anatomical, physiological and biochemical features of swine rather than rodents to humans. On this basis, we have produced the first swine ALS model by in vitro transfection of cultured somatic cells combined with somatic cell nuclear transfer (SCNT). To achieve this goal we developed a SOD1G93A (superoxide dismutase 1 mutated in Gly93-Ala) vector, capable of promoting a high and stable transgene expression in primary porcine adult male fibroblasts (PAF). After transfection, clonal selection and transgene expression level assessment, selected SOD1G93A PAF colonies were used as nuclei donors in SCNT procedures. SOD1G93A embryos were transferred in recipient sows, and pregnancies developed to term. A total of 5 piglets survived artificial hand raising and weaning and developed normally, reaching adulthood. Preliminary analysis revealed transgene integration and hSOD1G93A expression in swine tissues and 360° phenotypical characterization is ongoing. We believe that our SOD1G93A swine would provide an essential bridge between the fundamental work done in rodent models and the reality of treating ALS.

Original languageEnglish
Pages (from-to)246-254
Number of pages9
JournalNeurodegenerative Diseases
Volume13
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Amyotrophic Lateral Sclerosis
Swine
Transgenes
Transfection
Rodentia
Fibroblasts
Genes
Mutation
Weaning
Research
Codon
Neurodegenerative Diseases
Alanine
Glycine
Primates
Transgenic Mice
Cultured Cells
Embryonic Structures
Hand
Superoxide Dismutase-1

Keywords

  • Amyotrophic lateral sclerosis
  • Animal model
  • Cu/Zn superoxide dismutase 1
  • Pig
  • Somatic cell nuclear transfer
  • Swine

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Chieppa, M. N., Perota, A., Corona, C., Grindatto, A., Lagutina, I., Costassa, E. V., ... Casalone, C. (2014). Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine. Neurodegenerative Diseases, 13(4), 246-254. https://doi.org/10.1159/000353472

Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine. / Chieppa, M. N.; Perota, A.; Corona, C.; Grindatto, A.; Lagutina, I.; Costassa, E. Vallino; Lazzari, G.; Colleoni, S.; Duchi, R.; Lucchini, F.; Caramelli, M.; Bendotti, C.; Galli, C.; Casalone, C.

In: Neurodegenerative Diseases, Vol. 13, No. 4, 2014, p. 246-254.

Research output: Contribution to journalArticle

Chieppa, MN, Perota, A, Corona, C, Grindatto, A, Lagutina, I, Costassa, EV, Lazzari, G, Colleoni, S, Duchi, R, Lucchini, F, Caramelli, M, Bendotti, C, Galli, C & Casalone, C 2014, 'Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine', Neurodegenerative Diseases, vol. 13, no. 4, pp. 246-254. https://doi.org/10.1159/000353472
Chieppa MN, Perota A, Corona C, Grindatto A, Lagutina I, Costassa EV et al. Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine. Neurodegenerative Diseases. 2014;13(4):246-254. https://doi.org/10.1159/000353472
Chieppa, M. N. ; Perota, A. ; Corona, C. ; Grindatto, A. ; Lagutina, I. ; Costassa, E. Vallino ; Lazzari, G. ; Colleoni, S. ; Duchi, R. ; Lucchini, F. ; Caramelli, M. ; Bendotti, C. ; Galli, C. ; Casalone, C. / Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine. In: Neurodegenerative Diseases. 2014 ; Vol. 13, No. 4. pp. 246-254.
@article{8856d62ab5a94be9b3884f0415a26fc0,
title = "Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine",
abstract = "Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that occurs in two clinically indistinguishable forms: sporadic (SALS) and familial (FALS), the latter linked to several gene mutations, mostly inheritable in a dominant manner. Nearly 20{\%} of FALS forms are linked to mutations in the Cu/Zn superoxide dismutase (SOD1) gene. Research on ALS relies on transgenic models and particularly on mice carrying a glycine-to-alanine conversion at the 93rd codon (G93A) of the hSOD1 gene. Although G93A transgenic mice have been widely employed in clinical trials and basic research, doubts have been recently raised from numerous reliable sources about their suitability to faithfully reproduce human disease. Besides, the scientific community has already foreseen swine as an attractive and alternative model to nonhuman primates for modeling human diseases due to closer anatomical, physiological and biochemical features of swine rather than rodents to humans. On this basis, we have produced the first swine ALS model by in vitro transfection of cultured somatic cells combined with somatic cell nuclear transfer (SCNT). To achieve this goal we developed a SOD1G93A (superoxide dismutase 1 mutated in Gly93-Ala) vector, capable of promoting a high and stable transgene expression in primary porcine adult male fibroblasts (PAF). After transfection, clonal selection and transgene expression level assessment, selected SOD1G93A PAF colonies were used as nuclei donors in SCNT procedures. SOD1G93A embryos were transferred in recipient sows, and pregnancies developed to term. A total of 5 piglets survived artificial hand raising and weaning and developed normally, reaching adulthood. Preliminary analysis revealed transgene integration and hSOD1G93A expression in swine tissues and 360° phenotypical characterization is ongoing. We believe that our SOD1G93A swine would provide an essential bridge between the fundamental work done in rodent models and the reality of treating ALS.",
keywords = "Amyotrophic lateral sclerosis, Animal model, Cu/Zn superoxide dismutase 1, Pig, Somatic cell nuclear transfer, Swine",
author = "Chieppa, {M. N.} and A. Perota and C. Corona and A. Grindatto and I. Lagutina and Costassa, {E. Vallino} and G. Lazzari and S. Colleoni and R. Duchi and F. Lucchini and M. Caramelli and C. Bendotti and C. Galli and C. Casalone",
year = "2014",
doi = "10.1159/000353472",
language = "English",
volume = "13",
pages = "246--254",
journal = "Neurodegenerative Diseases",
issn = "1660-2854",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Modeling amyotrophic lateral sclerosis in hSOD1G93A transgenic swine

AU - Chieppa, M. N.

AU - Perota, A.

AU - Corona, C.

AU - Grindatto, A.

AU - Lagutina, I.

AU - Costassa, E. Vallino

AU - Lazzari, G.

AU - Colleoni, S.

AU - Duchi, R.

AU - Lucchini, F.

AU - Caramelli, M.

AU - Bendotti, C.

AU - Galli, C.

AU - Casalone, C.

PY - 2014

Y1 - 2014

N2 - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that occurs in two clinically indistinguishable forms: sporadic (SALS) and familial (FALS), the latter linked to several gene mutations, mostly inheritable in a dominant manner. Nearly 20% of FALS forms are linked to mutations in the Cu/Zn superoxide dismutase (SOD1) gene. Research on ALS relies on transgenic models and particularly on mice carrying a glycine-to-alanine conversion at the 93rd codon (G93A) of the hSOD1 gene. Although G93A transgenic mice have been widely employed in clinical trials and basic research, doubts have been recently raised from numerous reliable sources about their suitability to faithfully reproduce human disease. Besides, the scientific community has already foreseen swine as an attractive and alternative model to nonhuman primates for modeling human diseases due to closer anatomical, physiological and biochemical features of swine rather than rodents to humans. On this basis, we have produced the first swine ALS model by in vitro transfection of cultured somatic cells combined with somatic cell nuclear transfer (SCNT). To achieve this goal we developed a SOD1G93A (superoxide dismutase 1 mutated in Gly93-Ala) vector, capable of promoting a high and stable transgene expression in primary porcine adult male fibroblasts (PAF). After transfection, clonal selection and transgene expression level assessment, selected SOD1G93A PAF colonies were used as nuclei donors in SCNT procedures. SOD1G93A embryos were transferred in recipient sows, and pregnancies developed to term. A total of 5 piglets survived artificial hand raising and weaning and developed normally, reaching adulthood. Preliminary analysis revealed transgene integration and hSOD1G93A expression in swine tissues and 360° phenotypical characterization is ongoing. We believe that our SOD1G93A swine would provide an essential bridge between the fundamental work done in rodent models and the reality of treating ALS.

AB - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that occurs in two clinically indistinguishable forms: sporadic (SALS) and familial (FALS), the latter linked to several gene mutations, mostly inheritable in a dominant manner. Nearly 20% of FALS forms are linked to mutations in the Cu/Zn superoxide dismutase (SOD1) gene. Research on ALS relies on transgenic models and particularly on mice carrying a glycine-to-alanine conversion at the 93rd codon (G93A) of the hSOD1 gene. Although G93A transgenic mice have been widely employed in clinical trials and basic research, doubts have been recently raised from numerous reliable sources about their suitability to faithfully reproduce human disease. Besides, the scientific community has already foreseen swine as an attractive and alternative model to nonhuman primates for modeling human diseases due to closer anatomical, physiological and biochemical features of swine rather than rodents to humans. On this basis, we have produced the first swine ALS model by in vitro transfection of cultured somatic cells combined with somatic cell nuclear transfer (SCNT). To achieve this goal we developed a SOD1G93A (superoxide dismutase 1 mutated in Gly93-Ala) vector, capable of promoting a high and stable transgene expression in primary porcine adult male fibroblasts (PAF). After transfection, clonal selection and transgene expression level assessment, selected SOD1G93A PAF colonies were used as nuclei donors in SCNT procedures. SOD1G93A embryos were transferred in recipient sows, and pregnancies developed to term. A total of 5 piglets survived artificial hand raising and weaning and developed normally, reaching adulthood. Preliminary analysis revealed transgene integration and hSOD1G93A expression in swine tissues and 360° phenotypical characterization is ongoing. We believe that our SOD1G93A swine would provide an essential bridge between the fundamental work done in rodent models and the reality of treating ALS.

KW - Amyotrophic lateral sclerosis

KW - Animal model

KW - Cu/Zn superoxide dismutase 1

KW - Pig

KW - Somatic cell nuclear transfer

KW - Swine

UR - http://www.scopus.com/inward/record.url?scp=84900310785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900310785&partnerID=8YFLogxK

U2 - 10.1159/000353472

DO - 10.1159/000353472

M3 - Article

C2 - 24157939

AN - SCOPUS:84900310785

VL - 13

SP - 246

EP - 254

JO - Neurodegenerative Diseases

JF - Neurodegenerative Diseases

SN - 1660-2854

IS - 4

ER -